This message was sent to ##Email##
|
|
|
|
|
| |
The White House
The White House Office of Science & Technology Policy (OSTP) has announced an open call for commitments focused on addressing the organ shortage. Individuals and organizations are invited to submit information on new initiatives that have the ability to decrease the transplant wait list. A blog published last week provides additional information including the commitment criteria and the timeline.
AST
Visit the AST Member Spotlight section of the website to find out what transplantation means to Dr. Joanna Schaenman and why she chose to work in this exciting field!
Interested in being featured in the AST Member Spotlight? Please contact rmassi@myAST.org for more information.
 |
|
• Write quality plans
• Document F-QAPI activities
• Review adverse events
• Assign tasks and to-do's
• Create meeting agendas and minutes
• Automate QA scorecards and reporting
• Analyze outcomes
|
|
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Oct. 26, 2016 1 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program-1
FDA
On Sept. 27, 2016, the FDA is conducting a public meeting on Patients Who Have Received an Organ Transplant. FDA is interested in obtaining patient input on the impact of receiving an organ transplant on daily life and patients’ views on currently available therapies to manage organ transplantation. To register to attend the meeting, either in person or via web, please visit this link.
Register today!
BeST16 Basic Science in Transplantation
The basic science community within our field is a tight-knit, dynamic group that benefits greatly from dedicated meeting opportunities to share knowledge and establish collaborations. As such, we hope you will join us at BeST16: Basic Science in Transplantation, a meeting jointly sponsored by the AST and ESOT.
HOUSING IS NOW OPEN
Clinical Transplantation
Thrombosis of the pancreas after transplantation is the most common cause of relaparotomy and resultant graft loss. There is currently no standard protocol consistently proven to prevent thrombosis following transplantation. Our objective was to determine whether our protocol of post-operative low-dose intravenous (IV) heparin infusion would prevent graft thrombosis without additional complications in our patients.
READ MORE
Pediatric Transplantation
Optimal strategies to prevent cytomegalovirus (CMV) disease following pediatric solid organ transplantation remain controversial. The purpose of this study was to review the outcomes of a risk-stratified strategy that uses a hybrid or prophylactic strategy for donor (D)+ recipient (R)− patients, a preemptive strategy for D+R+/D−R+, and clinical follow-up alone for D−R+ patients. A retrospective chart review was undertaken at the Stollery Children's Hospital in Edmonton, Alberta for pediatric solid organ transplants 2004 through 2010.
READ MORE
American Journal of Transplantation
The complement system plays a critical role in ischemia–reperfusion injury (IRI)–mediated delayed graft function (DGF). To better understand the roles of complement activation pathways in IRI in kidney transplantation, donor kidneys were treated ex vivo with terminal complement pathway (TP) inhibitor, anti-rat C5 mAb 18A10, or complement alternative pathway (AP) inhibitor TT30 for 28 h at 4°C pretransplantation in a syngeneic kidney transplantation rat model.
READ MORE
Transplant Infectious Disease
We have read with great interest the recent article by Crepin et al.1 on the clinical impact of an immune risk phenotype (IRP) on the susceptibility to post-transplant infection in a cohort of 486 patients with end-stage renal disease (ESRD) undergoing kidney transplantation (KT). By using some broadly available parameters (namely peripheral blood lymphocyte subpopulations [PBLSs] and cytomegalovirus [CMV] serostatus), the so-called IRP aims to summarize the spectrum of functional changes involved in the CMV-driven process of premature immune senescence.
READ MORE
Liver Transplantation
Liver transplantation (LT) recipients in the United States have low rates of paid employment, making some eligible for Medicaid public health insurance after transplant. We test whether recent expansions of Medicaid eligibility increased Medicaid enrollment and insurance coverage in this population. Patients of ages 18-59 years receiving first-time LTs in 2009-2013 were identified in the United Network for Organ Sharing registry and stratified according to insurance at transplantation (private versus Medicaid/Medicare).
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
